{"id":"https://openalex.org/W1967501451","doi":"https://doi.org/10.1007/s13300-014-0076-9","title":"Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials","display_name":"Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials","alternate_titles":[],"publication_year":2014,"publication_date":"2014-07-31","ids":{"openalex":"https://openalex.org/W1967501451","doi":"https://doi.org/10.1007/s13300-014-0076-9","mag":"1967501451","pmid":"https://pubmed.ncbi.nlm.nih.gov/25081590","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4269648"},"language":"en","primary_location":{"id":"doi:10.1007/s13300-014-0076-9","doi":"https://doi.org/10.1007/s13300-014-0076-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-014-0076-9","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-014-0076-9.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1967501451"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s13300-014-0076-9.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090192766","display_name":"Jiten P Vora","orcid":"https://orcid.org/0000-0002-3488-5287","observed_orcids":["https://orcid.org/0000-0002-3488-5287"]},"institutions":[{"id":"https://openalex.org/I2802775644","display_name":"Royal Liverpool University Hospital","ror":"https://ror.org/01ycr6b80","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802729160","https://openalex.org/I2802775644"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Jiten Vora","raw_affiliation_strings":["Department of Diabetes and Endocrinology, Royal Liverpool University Hospitals, Prescot Street, Liverpool, L7 8XP, UK, jiten.vora@rlbuht.nhs.uk","Department of Diabetes and Endocrinology, Royal Liverpool University Hospitals, Liverpool, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetes and Endocrinology, Royal Liverpool University Hospitals, Prescot Street, Liverpool, L7 8XP, UK, jiten.vora@rlbuht.nhs.uk","institution_ids":["https://openalex.org/I2802775644"]},{"raw_affiliation_string":"Department of Diabetes and Endocrinology, Royal Liverpool University Hospitals, Liverpool, UK","institution_ids":["https://openalex.org/I2802775644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110252289","display_name":"Torsten Christensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Torsten Christensen","raw_affiliation_strings":["Health Economics, Novo Nordisk A/S, S\u00f8borg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics, Novo Nordisk A/S, S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111912516","display_name":"Azhar Rana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]},{"id":"https://openalex.org/I4405268700","display_name":"Novo Nordisk Canada (Canada)","ror":"https://ror.org/01th56526","country_code":"CA","type":"company","lineage":["https://openalex.org/I4405268700"]}],"countries":["CA","DK"],"is_corresponding":false,"raw_author_name":"Azhar Rana","raw_affiliation_strings":["Global Medical Affairs, Novo Nordisk A/S, S\u00f8borg, Denmark","Novo Nordisk Canada Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medical Affairs, Novo Nordisk A/S, S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I189090001"]},{"raw_affiliation_string":"Novo Nordisk Canada Inc","institution_ids":["https://openalex.org/I4405268700"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108210630","display_name":"Steve C Bain","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steve C. Bain","raw_affiliation_strings":["Department of Diabetes and Endocrinology, Abertawe Bro Morgannwg University NHS Trust, Swansea, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetes and Endocrinology, Abertawe Bro Morgannwg University NHS Trust, Swansea, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5090192766"],"corresponding_institution_ids":["https://openalex.org/I2802775644"],"apc_list":{"value":7400,"currency":"USD","value_usd":7400},"apc_paid":{"value":7400,"currency":"USD","value_usd":7400},"fwci":1.9888,"has_fulltext":true,"cited_by_count":99,"citation_normalized_percentile":{"value":0.88579017,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"5","issue":"2","first_page":"435","last_page":"446"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.031099999323487282,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-degludec","display_name":"insulin degludec","score":0.9459999799728394},{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":1.0},{"id":"https://openalex.org/keywords/basal-insulin","display_name":"basal insulin","score":0.7099999785423279},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.9819999933242798},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":1.0},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7059999704360962},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9409999847412109},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.9909999966621399},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8539999723434448},{"id":"https://openalex.org/keywords/nocturnal-hypoglycemia","display_name":"nocturnal hypoglycemia","score":0.921999990940094},{"id":"https://openalex.org/keywords/total-daily-insulin-dose","display_name":"total daily insulin dose","score":0.843999981880188},{"id":"https://openalex.org/keywords/insulin-naive-patients","display_name":"insulin-naive patients","score":0.6359999775886536},{"id":"https://openalex.org/keywords/multiple-daily-injections","display_name":"multiple daily insulin injections","score":0.8650000095367432},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.5289999842643738},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8080000281333923},{"id":"https://openalex.org/keywords/insulin-analogs","display_name":"insulin analogues","score":0.3070000112056732}],"concepts":[{"id":"https://openalex.org/C2775927303","wikidata":"https://www.wikidata.org/wiki/Q16252338","display_name":"Insulin degludec","level":5,"score":0.9769976735115051},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.891089677810669},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8379900455474854},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6672114133834839},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6138330698013306},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5646757483482361},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.555321455001831},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5093901753425598},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.44131535291671753},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.4375801086425781},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.41688427329063416},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32701462507247925}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1007/s13300-014-0076-9","doi":"https://doi.org/10.1007/s13300-014-0076-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-014-0076-9","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-014-0076-9.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},{"id":"pmid:25081590","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25081590","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes therapy : research, treatment and education of diabetes and related disorders","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4269648","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4269648/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Ther","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.774.6609","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.774.6609","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/f5/0b/13300_2014_Article_76.PMC4269648.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1007/s13300-014-0076-9","doi":"https://doi.org/10.1007/s13300-014-0076-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-014-0076-9","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-014-0076-9.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1967501451.pdf","grobid_xml":"https://content.openalex.org/works/W1967501451.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W181320477","https://openalex.org/W1565099151","https://openalex.org/W1658549429","https://openalex.org/W1953393606","https://openalex.org/W1965832529","https://openalex.org/W1979638334","https://openalex.org/W1986874694","https://openalex.org/W1994662102","https://openalex.org/W2006800582","https://openalex.org/W2006877643","https://openalex.org/W2030473729","https://openalex.org/W2044617125","https://openalex.org/W2050756416","https://openalex.org/W2101427076","https://openalex.org/W2106459655","https://openalex.org/W2124282046","https://openalex.org/W2126781806","https://openalex.org/W2146026006","https://openalex.org/W2161557127","https://openalex.org/W2615066072","https://openalex.org/W2917207274","https://openalex.org/W6737935307"],"related_works":["https://openalex.org/W796717900","https://openalex.org/W1658549429","https://openalex.org/W2789777142","https://openalex.org/W2041226218","https://openalex.org/W4307727383","https://openalex.org/W1969344491","https://openalex.org/W2941812001","https://openalex.org/W1979310371","https://openalex.org/W2322085534","https://openalex.org/W2332193413"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Insulin":[1],"degludec":[2,23,118,128,141,210,227],"(degludec)":[3],"is":[4,211,228],"a":[5,34],"basal":[6],"insulin":[7,25,41,90,135,242],"with":[8,24,108,127,140,208,213,231],"an":[9],"ultra-long,":[10],"stable":[11],"action":[12],"profile":[13],"and":[14,69,92,104,119,131,144,158,178,197,217,225,237],"reduced":[15],"pharmacodynamic":[16],"variability.":[17],"Seven":[18],"phase":[19],"3a":[20],"trials":[21,54],"compared":[22],"glargine":[26],"(glargine).":[27],"Patient-level":[28],"meta-analyses":[29],"were":[30,48,55,75,82,115,124,152,188],"performed":[31],"to":[32,202],"obtain":[33],"comprehensive":[35],"overview":[36],"of":[37,53,241],"differences":[38],"between":[39,117],"the":[40],"preparations,":[42],"possible":[43],"because":[44],"consistent":[45],"outcome":[46],"definitions":[47],"utilized.":[49],"METHODS:":[50],"Three":[51],"categories":[52],"analyzed:":[56],"basal-bolus-treated":[57,70],"type":[58,64],"1":[59],"diabetes":[60,66],"mellitus":[61,67],"(T1DMB/B),":[62],"insulin-na\u00efve":[63],"2":[65],"(T2DMinsulin-na\u00efve),":[68],"T2DM":[71],"(T2DMB/B).":[72],"Regression":[73],"models":[74],"adjusted":[76],"for":[77,150,155,185],"baseline":[78],"characteristics.":[79],"Endpoints":[80],"analyzed":[81,95,199],"glycosylated":[83],"hemoglobin":[84],"(HbA1c),":[85],"fasting":[86],"plasma":[87],"glucose":[88],"(FPG),":[89],"dose":[91,136],"hypoglycemic":[93],"rates":[94],"in":[96,113,122,129,142,235],"mutually":[97],"exclusive":[98],"groups:":[99],"non-severe":[100,102,161,170],"nocturnal,":[101],"daytime,":[103],"severe.":[105],"RESULTS:":[106],"As":[107],"previous":[109],"treat-to-target":[110],"trials,":[111],"reductions":[112,234],"HbA1c":[114,215],"similar":[116],"glargine.":[120,244],"Reductions":[121],"FPG":[123,236],"significantly":[125,138,218,232],"greater":[126,233],"T1DMB/B":[130,143,224],"T2DMinsulin-na\u00efve.":[132,145],"Total":[133],"daily":[134],"was":[137],"lower":[139,219,238],"Estimated":[146],"hypoglycemia":[147,221],"rate":[148],"ratios":[149,184],"degludec/glargine":[151],"as":[153],"follows":[154],"T1DMB/B,":[156],"T2DMinsulin-na\u00efve":[157],"T2DMB/B,":[159],"respectively:":[160],"nocturnal":[162,220],"0.83,":[163],"0.64,":[164],"0.75":[165],"(all":[166],"P":[167],"<":[168,181,194],"0.05);":[169],"daytime":[171],"1.14":[172],"[not":[173],"significant":[174],"(ns)],":[175],"0.89":[176],"(ns),":[177],"0.83":[179],"(P":[180,193],"0.05).":[182],"Rate":[183],"severe":[186],"events":[187],"1.12":[189],"(ns)":[190],"(T1DMB/B);":[191],"0.14":[192],"0.05)":[195],"(T2DMinsulin-na\u00efve);":[196],"not":[198],"(T2DMB/B)":[200],"due":[201],"too":[203],"few":[204],"events.":[205],"CONCLUSIONS:":[206],"Compared":[207],"glargine,":[209],"associated":[212,230],"equivalent":[214],"control":[216],"rates.":[222],"In":[223],"T2DMinsulin-na\u00efve,":[226],"also":[229],"total":[239],"doses":[240],"versus":[243]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1967501451","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
